QID 355859

QID 355859: Amazon Linux Security Advisory for runc : ALAS2DOCKER-2023-026

Extremely large rsa keys in certificate chains can cause a client/server to expend significant cpu time verifying signatures.
With fix, the size of rsa keys transmitted during handshakes is restricted to <= 8192 bits.
Based on a survey of publicly trusted rsa keys, there are currently only three certificates in circulation with keys larger than this, and all three appear to be test certificates that are not actively deployed.
It is possible there are larger keys in use in private pkis, but we target the web pki, so causing breakage here in the interests of increasing the default safety of users of crypto/tls seems reasonable. (
( CVE-2023-29409)



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Medium - 5.3 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Please refer to Amazon advisory: ALAS2DOCKER-2023-026 for affected packages and patching details, or update with your package manager.
    Vendor References

    CVEs related to QID 355859

    CVE-2023-29409 |
    Software Advisories
    Advisory ID Software Component Link
    ALAS2DOCKER-2023-026 amazon linux 2 URL Logo alas.aws.amazon.com/AL2/ALASDOCKER-2023-026.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].